How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma

NCT06313411 | Unknown

• 1 other identifier: 8778
• Study Type: observational
• Target: 1
• Locations: 1 country
• Sites: 1

Brief Summary

Schwannomas are mainly benign tumors, which develop mainly in the skull or in the cervical region. Retroperitoneal location is rare, since it represents between 0.5 and 5% of scwhanomas. The malignant retroperitoneal form is, however, more common than in other locations. Retroperitoneal schwannoma is often discovered during the exploration of unexplained lumbo-pelvic pain, or in the face of compression of nearby organs. Abdominopelvic CT and magnetic resonance imaging are essential to characterize the mass and verify its extension. The precise diagnosis is based on the pathological examination of the part, and complete surgical excision is the standard treatment. Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.

Conditions

Endometriosis Pelvic

Keywords

Endometriosis Pelvic; Schwannomas

Outcome Measures

Primary Outcomes (1)

• laparoscopic removal of a retroperitoneal pelvic schwannoma

  The aim of this research is to train surgeons to perform laparoscopic removal of a retroperitoneal pelvic schwanoma

  Through study completion, an average of 1 month

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

\- Adult patient (≥18 years old) having received treatment at the Strasbourg University Hospital during 2021 for a retro-peritoneal pelvic carcinoma

You may qualify if:

• Adult patient (≥18 years old)
• suffering from symptomatic deep pelvic endometriosis
• having received treatment at the Strasbourg University Hospital during 2021 for a retro-peritoneal pelvic carcinoma
• having not expressed, after information, the reuse of their data for the purposes of this research.

You may not qualify if:

• Patient who expressed her opposition to participating in the study

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de Gynécologie Obstétrique - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Neurilemmoma

Condition Hierarchy (Ancestors)

Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neuroma; Nerve Sheath Neoplasms; Neoplasms, Nerve Tissue

Central Study Contacts

Emilie FALLER, MD

CONTACT

33 3 88 12 63 87; emilie.faller@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 14, 2023
• First Posted: March 15, 2024
• Study Start: November 23, 2022
• Primary Completion: April 1, 2024
• Study Completion: April 1, 2024
• Last Updated: March 15, 2024

Record last verified: 2023-12

Locations

FR (1)